Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ashland

50.50
+0.95001.92%
Volume:227.55K
Turnover:11.50M
Market Cap:2.38B
PE:-110.13
High:50.98
Open:49.73
Low:49.73
Close:49.55
Loading ...

Argus Research Sticks to Their Buy Rating for Ashland (ASH)

TIPRANKS
·
03 Jan

Ashland Inks Deal to Sell Avoca Business to Optimize Portfolio

Zacks
·
30 Dec 2024

Press Release: Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

Dow Jones
·
27 Dec 2024

Ashland to Sell Off Fragrance-Fixative Business

Dow Jones
·
24 Dec 2024

BRIEF-Ashland Signs Definitive Agreement To Sell Avoca Business To Mane

Reuters
·
24 Dec 2024

Ashland to sell Avoca business to Mane, terms not disclosed

TIPRANKS
·
24 Dec 2024

Ashland Signs Definitive Agreement to Sell Avoca Business to Mane

THOMSON REUTERS
·
24 Dec 2024

Ashland signs definitive agreement to sell Avoca business to Mane

GlobeNewswire
·
24 Dec 2024

Aptose Announces Positive Decision by Nasdaq Hearings Panel

GlobeNewswire
·
20 Dec 2024

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease

GlobeNewswire
·
18 Dec 2024

New Strong Sell Stocks for November 18th

Zacks
·
18 Dec 2024

Evercore ISI Remains a Hold on Ashland (ASH)

TIPRANKS
·
18 Dec 2024

Ashland price target lowered to $85 from $100 at Evercore ISI

TIPRANKS
·
18 Dec 2024

Ashland Inc : Mizuho Cuts Target Price to $85 From $95

THOMSON REUTERS
·
17 Dec 2024

Ingevity elects Kevin Willis to its board of directors

Business Wire
·
17 Dec 2024

New Strong Sell Stocks for December 12th

Zacks
·
12 Dec 2024

Analysts Offer Insights on Materials Companies: Ashland (ASH), Vista Gold (VGZ) and Vizsla Silver (VZLA)

TIPRANKS
·
12 Dec 2024

Ashland Is Maintained at Overweight by Wells Fargo

Dow Jones
·
12 Dec 2024

Ashland price target raised to $84 from $83 at BMO Capital

TIPRANKS
·
11 Dec 2024

Genmab to Hold 2024 R&D Update and ASH Data Review Meeting

GlobeNewswire
·
11 Dec 2024